Helicobacter pylori blood biomarker for gastric cancer risk in East Asia

International Journal of Epidemiology

Volumn 45, Issue 3, 2016, Pages 774-781

  Cai, Hui ^a   Ye, Fei ^b   Michel, Angelika ^c   Murphy, Gwen ^d   Sasazuki, Shizuka ^e   Taylor, Philip R ^d   Qiao, You Lin ^f   Park, Sue K ^g   Yoo, Keun Young ^g   Jee, Sun Ha ^h   Cho, Eo Rin ^h   Kim, Jeongseon ⁱ   Chen, Sheau Chiann ^b   Abnet, Christian C ^d   Tsugane, Shoichiro ^e   Cai, Qiuyin ^a   Shu, Xiao Ou ^a   Zheng, Wei ^a   Pawlita, Michael ^c   Epplein, Meira ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL CANCER CENTER   (Japan)

^f PEKING UNION MEDICAL COLLEGE   (China)

^g Seoul National University College of Medicine   (South Korea)

^h Yonsei University   (South Korea)

ⁱ National Cancer Center   (South Korea)

Author keywords

Biomarkers; East Asia; Gastric cancer; Helicobacter pylori; Stomach neoplasms

Indexed keywords

ACETYLSALICYLIC ACID; BACTERIAL PROTEIN; CAGA PROTEIN; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CATALASE; CHAPERONIN 60; HCPC PROTEIN; HP0305 PROTEIN; HPAA PROTEIN; HYUA PROTEIN; NAPA PROTEIN; OMP PROTEIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR; BACTERIUM ANTIBODY; BIOLOGICAL MARKER;

ANTIBODY; BIOMARKER; BLOOD; CANCER; CONFIDENCE INTERVAL; DISEASE INCIDENCE; HEALTH RISK; INFECTIOUS DISEASE; MORTALITY; REGRESSION ANALYSIS; VIRULENCE;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; DRUG USE; FOOD INTAKE; FRUIT; HELICOBACTER PYLORI; HUMAN; JAPAN; KOREA; MIDDLE AGED; PRIORITY JOURNAL; STOMACH CANCER; VEGETABLE; BLOOD; FAR EAST; FEMALE; HELICOBACTER INFECTION; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; ODDS RATIO; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STOMACH TUMOR;

FAR EAST;

HELICOBACTER PYLORI;

ANTIBODIES, BACTERIAL; BIOMARKERS; CASE-CONTROL STUDIES; FAR EAST; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 85004191090     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyw078     Document Type: Article

References (23)

1. Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. 2013. http://globocan.iarc.fr (13 March 2014, date last accessed)
2. Fock KM, Katelaris P, Sugano K et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587-600
3. Fock KM, Talley N, Moayyedi P et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008;23:351-65
4. Epplein M, Zheng W, Xiang YB et al. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev 2012;21:2185-92
5. Li B, Taylor PR, Li JY et al. Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance. Ann Epidemiol 1993; 3):577-85
6. Zheng W, Chow WH, Yang G et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162):1123-31
7. Shu XO, Li H, Yang G et al. Cohort Profile: The Shanghai Men's Health Study. Int J Epidemiol 2015;44:810-08
8. Tsugane S, Sobue T. Baseline survey of JPHC study- design and participation rate. Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. J Epidemiol 2001;11(Suppl 6):S24-29
9. Jo J, Nam CM, Sull JW et al. Prediction of Colorectal Cancer Risk Using a Genetic Risk Score: The Korean Cancer Prevention Study-II (KCPS-II). Genomics Informs 2012;10:175-83
10. Yoo KY, Shin HR, Chang SH et al. Korean Multi-center Cancer Cohort Study including a Biological Materials Bank (KMCC-I). Asia Pac J Cancer Prev 2002;3:85-92
11. Kim J. Cancer Screenee Cohort Study of the National Cancer Center in South Korea. Epidemiol Health 2014;36:e2014013
12. Michel A, Waterboer T, Kist M, Pawlita M. Helicobacter pylori multiplex serology. Helicobacter 2009;14:525-35
13. Waterboer T, Sehr P, MichaelKM et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 2005;51:1845-53
14. Karnes WE Jr, Samloff IM, Siurala M et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101: 167-74
15. Kokkola A, Kosunen TU, Puolakkainen P et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619-24
16. Murphy G., Freedman ND, Michel A et al. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort. Int J Cancer 2015;137: 1938-46
17. Song H, Michel A, Nyren O, Ekstrom AM, Pawlita M, Ye W. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology. Int J Cancer 2014;134:2942-50
18. de Sablet T, Piazuelo MB, Shaffer CL et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 2011;60:1189-95
19. Gao L, Michel A, Weck MN, Arndt V, Pawlita M, Brenner H. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res 2009;69:6164-70
20. Laurén P. The two histological types of gastric carcinoma: diffuse and so-called intestinal type carcinoma: an attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49
21. Wong HL, Rabkin CS, Shu XO et al. Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women. Cancer Sci 2011;102):1911-15
22. Plummer M, Franceschi S, Vifnat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer 2015;136:487-90
23. Zhao Z, Li Y, Fu W. Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries. Tumour Biol 2014;35: 12217-24